J.P. Turner & Co Capital Management’s Pfizer PFE Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$454K	Sell	15,309 -1,854	-11%	-$59.4K	0.47%	62
2015 Q2	$548K	Buy	17,163 +1,776	+12%	+$57.9K	0.43%	78
2015 Q1	$505K	Sell	15,387 -254	-2%	-$8.07K	0.47%	67
2014 Q4	$463K	Buy	+15,641	New	+$448K	0.45%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

J.P. Turner & Co Capital Management's PFE Position: Q3 2015 in Review

J.P. Turner & Co Capital Management reduced its Pfizer (PFE) stake by 11% in Q3 2015, selling an estimated $59.4K and leaving 15,309 shares worth $454K. The position accounts for 0.47% of the portfolio, ranked #62.

J.P. Turner & Co Capital Management first reported a position in PFE in Q4 2014 and has held it in 4 quarters since. The position peaked at $548K in Q2 2015. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

J.P. Turner & Co Capital Management held 15,309 shares of Pfizer worth $454K as of Q3 2015.
J.P. Turner & Co Capital Management sold 1,854 Pfizer shares in Q3 2015, an estimated $59.4K.
Pfizer made up 0.47% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #62 holding.
J.P. Turner & Co Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 4 quarters since.
J.P. Turner & Co Capital Management's Pfizer position peaked at $548K in Q2 2015.
1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.